Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Wilhelm Mistiaen"'
Publikováno v:
Prosthesis, Vol 6, Iss 3, Pp 708-725 (2024)
Surgical aortic valve replacement (SAVR) was the only symptom relieving and life-prolonging treatment until transcatheter aortic valve implantation (TAVI) became available. This option was introduced to treat old and high-risk patients. In a series o
Externí odkaz:
https://doaj.org/article/36b08b969f3f4fe2bd95f90cf592b4fa
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 5, p 136 (2024)
Surgical aortic valve replacement (SAVR) with a biological heart valve prosthesis (BHV) is often used as a treatment in elderly patients with symptomatic aortic valve disease. This age group is also at risk for the development of dementia in the year
Externí odkaz:
https://doaj.org/article/69f3860e86f94b0d99128f6955c336a8
Publikováno v:
Geriatrics, Vol 9, Iss 2, p 44 (2024)
Aortic valve disease is a lethal condition, once it becomes symptomatic. Surgical aortic valve replacement (SAVR) has, for a long time, been the only treatment option. In patients aged 85 and older, the consequences of SAVR have rarely been investiga
Externí odkaz:
https://doaj.org/article/17e33abe795f43bc8b013384109b0537
Autor:
Wilhelm Mistiaen
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 5, p 223 (2023)
Transcatheter aortic valve implantation (TAVI) was first presented in 2002 as a case report. Randomized controlled trials showed that TAVI could serve as an alternative for surgical aortic valve replacement (SAVR) in high-risk patients. While the ind
Externí odkaz:
https://doaj.org/article/2e74bf868d8148a3806283619042e1f2
